Moreover, we have also discovered caveolin-1 as a potential clinical biomarker for lung cancer which could be used in clinical setting to monitor patient’s response to radiation therapy and recurrence (Fig 9) [14]. This evidence concerns the gene CAV1 and lung carcinoma.